Primmune Therapeutics raised $8.6M Series B Plus venture round.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Venture Capital | — |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$55M
Top Valuation
-
Primmune Therapeutics raised $8.6M in a Series B Plus round.
The round was announced on 01/30/26.